glp 1 blue cross blue shield of Mass. sees gains after years of GLP-1-related losses Excellus clarifies GLP-1 coverage ahead

*Based on manufacturer trials studying the highest doses of oral and injectable Wegovy in non-diabetics with obesity, or with overweight plus a weight-related medical condition, when paired with diet and exercise changes (vs ~2% with diet and exercise alone)

Both the semaglutide vial and the bacteriostatic water vial need cleaning before you insert a needle

No, you are not required to take a blood test before receiving the injection

Beyond regulating blood sugar, GLP-1 receptor agonists reduce systemic inflammation, improve insulin sensitivity and promote weight loss all factors that can dampen tumor-promoting pathways

Eyunni S, Mannan R, Zhang Y, Young E, Zhang Q, Luo J, et al

Quality & Manufacturing All materials are sourced from carefully vetted domestic and international manufacturing partners who follow quality systems consistent with ISO and cGMP principles